Discover Junie inside JetBrains IDEs, with Ask mode plus Brave mode to confirm actions, so you ship safer updates with less ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...

CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...

If you're like many people, you're still getting your sea legs after the lunar eclipse earlier this month. Well buckle up, buttercup, because there's yet another change-up approaching with the March ...

Forbes contributors publish independent expert analyses and insights. An award-winning reporter writing about stargazing and the night sky. A rare sunrise solar eclipse will occur on Saturday, March ...

First patient enrolled in ECLIPSE 1 Phase 3 clinical trial evaluating combination of tobevibart and elebsiran for chronic suppressive treatment ECLIPSE program designed to enable regulatory ...

Microsoft is expanding functionality for agentic AI into its Azure AI Foundry platform, furthering one of the hottest areas of development right now. The company this week announced two new features, ...